Home › Funds › Patient Square Capital LP › ARGX
Patient Square Capital LP position in ARGX
Argenx S.E. · Health Care
Patient Square Capital LP reported holding 28,000 shares of ARGX (Argenx S.E.) in its Q3 2026 13F filing — a position valued at US$26.8M, representing 4.28% of its reported portfolio and ranking #4 among its reported holdings. Patient Square Capital LP has disclosed ARGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's ARGX position evolved
Patient Square Capital LP first disclosed a stake in ARGX in Q2 2025 at 29,000 shares (US$16.0M). The position peaked in Q3 2026 at 28,000 shares, worth US$26.8M. Across 6 filings, Patient Square Capital LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 28,000 shares valued at US$26.8M — an increase of 5,000 shares quarter over quarter.. Notable position changes include a 47% trim in Q3 2025 (shares rose 14% over the following quarter), a 68% increase in Q4 2025 (shares fell 13% over the following quarter), a 41% increase in Q1 2026 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 29.00K | $15.99M | New |
| Q3 2025 | 15.50K | $11.43M | Reduce |
| Q4 2025 | 26.00K | $21.86M | Add |
| Q1 2026 | 36.72K | $26.81M | Add |
| Q2 2026 | 23.00K | $21.34M | Reduce |
| Q3 2026 | 28.00K | $26.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARGX and 13F data
ARGX (Argenx S.E.) is a Health Care company. 36 other funds we track also report a position in ARGX — the largest reported positions include Jupiter Topco LLC (US$2.30B), Janus Henderson Group (US$1.85B), Artisan Partners Limited Partnership (US$1.12B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARGX
- Jupiter Topco LLC 2.47M sh · $2.30B · Q2 2026
- Janus Henderson Group 2.54M sh · $1.85B · Q1 2026
- Artisan Partners Limited Partnership 1.17M sh · $1.12B · Q3 2026
- Avoro Capital Advisors LLC 1.00M sh · $927.77M · Q2 2026
- RTW INVESTMENTS, LP 709.45K sh · $658.20M · Q2 2026
- Bellevue Group AG 301.00K sh · $279.26M · Q2 2026
- SANDS CAPITAL MANAGEMENT, LLC 270.21K sh · $259.10M · Q3 2026
- BESSEMER GROUP INC 264.85K sh · $253.96M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 247.40K sh · $237.20M · Q3 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 175.89K sh · $168.66M · Q3 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held ARGX?
Patient Square Capital LP has disclosed ARGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Patient Square Capital LP's current position in ARGX?
As of Q3 2026, Patient Square Capital LP holds 28.00K shares of ARGX (Argenx S.E.), valued at $26.85M, representing 4.28% of its reported portfolio and ranking #4.
Has Patient Square Capital LP been buying or selling ARGX?
In the latest 13F filing (Q3 2026), Patient Square Capital LP increased its position in ARGX. The position peaked in Q3 2026 at 28.00K shares.
Which other funds hold ARGX?
Other major institutional holders of ARGX include Jupiter Topco LLC, Janus Henderson Group, Artisan Partners Limited Partnership, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.